INvestigating DIGital Outcomes in the Community

Not yet recruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 1, 2025

Conditions
Cancer
Trial Locations (1)

W6 8RF

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
collaborator

Imperial College Healthcare NHS Trust

OTHER

lead

Imperial College London

OTHER

NCT06095024 - INvestigating DIGital Outcomes in the Community | Biotech Hunter | Biotech Hunter